Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms.
Babic A, Bao Y, Qian ZR, Yuan C, Giovannucci EL, Aschard H, Kraft P, Amundadottir LT, Stolzenberg-Solomon R, Morales-Oyarvide V, Ng K, Stampfer MJ, Ogino S, Buring JE, Sesso HD, Gaziano JM, Rifai N, Pollak MN, Anderson ML, Cochrane BB, Luo J, Manson JE, Fuchs CS, Wolpin BM. Babic A, et al. Among authors: kraft p. Cancer Res. 2016 Dec 15;76(24):7160-7167. doi: 10.1158/0008-5472.CAN-16-1699. Epub 2016 Oct 25. Cancer Res. 2016. PMID: 27780823 Free PMC article.
No association between GPX1 Pro198Leu and breast cancer risk.
Cox DG, Hankinson SE, Kraft P, Hunter DJ. Cox DG, et al. Among authors: kraft p. Cancer Epidemiol Biomarkers Prev. 2004 Nov;13(11 Pt 1):1821-2. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15533915 No abstract available.
CYP19 (aromatase) haplotypes and endometrial cancer risk.
Paynter RA, Hankinson SE, Colditz GA, Kraft P, Hunter DJ, De Vivo I. Paynter RA, et al. Among authors: kraft p. Int J Cancer. 2005 Aug 20;116(2):267-74. doi: 10.1002/ijc.21041. Int J Cancer. 2005. PMID: 15800924
Androgen receptor polymorphisms and endometrial cancer risk.
McGrath M, Lee IM, Hankinson SE, Kraft P, Hunter DJ, Buring J, De Vivo I. McGrath M, et al. Among authors: kraft p. Int J Cancer. 2006 Mar 1;118(5):1261-8. doi: 10.1002/ijc.21436. Int J Cancer. 2006. PMID: 16161040
Genetic variation in the HSD17B1 gene and risk of prostate cancer.
Kraft P, Pharoah P, Chanock SJ, Albanes D, Kolonel LN, Hayes RB, Altshuler D, Andriole G, Berg C, Boeing H, Burtt NP, Bueno-de-Mesquita B, Calle EE, Cann H, Canzian F, Chen YC, Crawford DE, Dunning AM, Feigelson HS, Freedman ML, Gaziano JM, Giovannucci E, Gonzalez CA, Haiman CA, Hallmans G, Henderson BE, Hirschhorn JN, Hunter DJ, Kaaks R, Key T, Le Marchand L, Ma J, Overvad K, Palli D, Pike MC, Riboli E, Rodriguez C, Setiawan WV, Stampfer MJ, Stram DO, Thomas G, Thun MJ, Travis R, Trichopoulou A, Virtamo J, Wacholder S. Kraft P, et al. PLoS Genet. 2005 Nov;1(5):e68. doi: 10.1371/journal.pgen.0010068. Epub 2005 Nov 25. PLoS Genet. 2005. PMID: 16311626 Free PMC article.
Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies.
Feigelson HS, Cox DG, Cann HM, Wacholder S, Kaaks R, Henderson BE, Albanes D, Altshuler D, Berglund G, Berrino F, Bingham S, Buring JE, Burtt NP, Calle EE, Chanock SJ, Clavel-Chapelon F, Colditz G, Diver WR, Freedman ML, Haiman CA, Hankinson SE, Hayes RB, Hirschhorn JN, Hunter D, Kolonel LN, Kraft P, LeMarchand L, Linseisen J, Modi W, Navarro C, Peeters PH, Pike MC, Riboli E, Setiawan VW, Stram DO, Thomas G, Thun MJ, Tjonneland A, Trichopoulos D. Feigelson HS, et al. Among authors: kraft p. Cancer Res. 2006 Feb 15;66(4):2468-75. doi: 10.1158/0008-5472.CAN-05-3574. Cancer Res. 2006. PMID: 16489054
1,194 results